Petros Family Wealth’s Gilead Sciences GILD Stock Holding History

Petros Family Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,931	Closed	-$271K	–	129
2024 Q4	$271K	Buy	+2,931	New	+$264K	0.29%	97

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Petros Family Wealth's GILD Position: Q1 2025 in Review

Petros Family Wealth sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 2,931 shares — an estimated $271K sold.

Petros Family Wealth first reported a position in GILD in Q4 2024 and held it in 1 quarter. The position peaked at $271K in Q4 2024. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Petros Family Wealth reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Petros Family Wealth sold 2,931 Gilead Sciences shares in Q1 2025, an estimated $271K.
Petros Family Wealth first reported a position in Gilead Sciences in Q4 2024 and held it in 1 quarter.
Petros Family Wealth's Gilead Sciences position peaked at $271K in Q4 2024.
2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Petros Family Wealth's 13F filing for Q1 2025, filed 23 Apr 2025.